Literature DB >> 1850451

Diffuse Lewy body disease presenting with a supranuclear gaze palsy.

J M Fearnley1, T Revesz, D J Brooks, R S Frackowiak, A J Lees.   

Abstract

A patient with diffuse Lewy body disease presented with supranuclear vertical and horizontal ophthalmoplegia, dementia, axial rigidity and falls, bradykinesia and pyramidal signs. This broadens the clinical presentation of this pathological diagnosis and re-emphasises the heterogeneity of patients diagnosed clinically as progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).

Entities:  

Mesh:

Year:  1991        PMID: 1850451      PMCID: PMC1014352          DOI: 10.1136/jnnp.54.2.159

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  Diffuse Lewy body disease with dementia and oculomotor dysfunction.

Authors:  A J Lewis; M J Gawel
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

3.  Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.

Authors:  G Lennox; J Lowe; M Landon; E J Byrne; R J Mayer; R B Godwin-Austen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-11       Impact factor: 10.154

4.  Analysis of cerebellar motor disorders by visually-guided elbow tracking movement. 2. Contribution of the visual cues on slow ramp pursuit.

Authors:  H Beppu; M Nagaoka; R Tanaka
Journal:  Brain       Date:  1987-02       Impact factor: 13.501

5.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

6.  Cortical changes in the parkinsonian brain: a contribution to the delineation of "diffuse Lewy body disease".

Authors:  M Yoshimura
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

7.  Vertical glaze paralysis and the rostral interstitial nucleus of the medial longitudinal fasciculus.

Authors:  J A Büttner-Ennever; U Büttner; B Cohen; G Baumgartner
Journal:  Brain       Date:  1982-03       Impact factor: 13.501

8.  Pain in sciatica depresses lower limb nociceptive reflexes to sural nerve stimulation.

Authors:  J C Willer; A Barranquero; M F Kahn; D Sallière
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-01       Impact factor: 10.154

9.  Progressive supranuclear palsy--20 years later.

Authors:  M O Kristensen
Journal:  Acta Neurol Scand       Date:  1985-03       Impact factor: 3.209

10.  Reversible supranuclear ophthalmoplegia associated with Parkinsonism.

Authors:  R J Guiloff; R J George; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-06       Impact factor: 10.154

  10 in total
  10 in total

Review 1.  Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature.

Authors:  Kumar Abhinav; Laura Marsh; Barbara Crain; Stephen G Reich; Kevin Biglan
Journal:  Neurol Sci       Date:  2010-08-25       Impact factor: 3.307

2.  Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.

Authors:  D J Burn; G V Sawle; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

3.  Resveratrol and pinostilbene confer neuroprotection against aging-related deficits through an ERK1/2-dependent mechanism.

Authors:  Erika N Allen; Sneha Potdar; Victor Tapias; Mayur Parmar; Cassia S Mizuno; Agnes Rimando; Jane E Cavanaugh
Journal:  J Nutr Biochem       Date:  2017-11-04       Impact factor: 6.048

4.  Pathologic correlates of supranuclear gaze palsy with parkinsonism.

Authors:  W R W Martin; J Hartlein; B A Racette; N Cairns; J S Perlmutter
Journal:  Parkinsonism Relat Disord       Date:  2017-02-24       Impact factor: 4.891

5.  Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

Authors:  S J Collins; J E Ahlskog; J E Parisi; D M Maraganore
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

6.  Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.

Authors:  N L Foster; S Gilman; S Berent; A A Sima; C D'Amato; R A Koeppe; S P Hicks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

7.  Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology.

Authors:  Heather B Rigby; Brittany N Dugger; Joseph G Hentz; Charles H Adler; Thomas G Beach; Holly A Shill; Erika Driver-Dunckley; Marwan N Sabbagh; Lucia I Sue; John N Caviness
Journal:  Mov Disord Clin Pract       Date:  2014-10-29

8.  Stereotaxic Intracranial Delivery of Chemicals, Proteins or Viral Vectors to Study Parkinson's Disease.

Authors:  Natalie Landeck; Melissa Conti Mazza; Megan Duffy; Christopher Bishop; Caryl E Sortwell; Mark R Cookson
Journal:  J Vis Exp       Date:  2021-02-18       Impact factor: 1.355

9.  Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy.

Authors:  María Elena Erro Aguirre; María Victoria Zelaya; Javier Sánchez Ruiz de Gordoa; María Teresa Tuñón; José Luis Lanciego
Journal:  Front Neuroanat       Date:  2015-03-11       Impact factor: 3.856

Review 10.  Clinical Approach to Supranuclear Brainstem Saccadic Gaze Palsies.

Authors:  Alexandra Lloyd-Smith Sequeira; John-Ross Rizzo; Janet C Rucker
Journal:  Front Neurol       Date:  2017-08-23       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.